The Associations of Neighborhood Availability of Marijuana Dispensaries and DATA-2000 Waivered Providers with Hospital Stays Related to Opioids

References

• Babitsch, B., Gohl, D., & von Lengerke, T. (2012). Re-revisiting Andersen’s behavioral model of health services use: A systematic review of studies from. GMS Psycho-Social-Medicine, 9, 1998–2011.
   Google Scholar
• Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Internal Medicine, 174, 1668–1673. doi:10.1001/jamainternmed.2014.4005
   PubMed Web of Science ®Google Scholar
• Bradford, A. C., & Bradford, W. D. (2016). Medical marijuana laws reduce prescription medication use in medicare part D. Health Affairs, 35, 1230–1236. doi:10.1377/hlthaff.2015.1661
   PubMed Web of Science ®Google Scholar
• Bradford, A. C., & Bradford, W. D. (2017). Medical marijuana laws may be associated with a decline in the number of prescriptions for medicaid enrollees. Health Affair, 36(5), 945–951. doi:10.1377/hlthaff.2016.1135
   Web of Science ®Google Scholar
• Bradford, A. C., Bradford, W. D., Abraham, A., & Adams, G. B. (2018). Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population. JAMA Internal Medicine, 178, 667–672. doi:10.1001/jamainternmed.2018.0266
   PubMed Web of Science ®Google Scholar
• Campbell, G., Hall, W. D., Peacock, A., Lintzeris, N., Bruno, R., Larance, B., … Degenhardt, L. (2018). Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: Findings from a 4-year prospective cohort study. The Lancet Public Health, 3, e341–e350. doi:10.1016/S2468-2667(18)30110-5
   PubMed Web of Science ®Google Scholar
• Caputi, T. L., & Humphreys, K. (2018). Medical marijuana users are more likely to use prescription drugs medically and nonmedically. Journal of Addiction Medicine, 12, 295–299. doi:10.1097/ADM.0000000000000405
   PubMed Web of Science ®Google Scholar
• CDC. (2011). Vital signs: Overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR-Morbid Mortal W, 60, 1487–1492.
   PubMedGoogle Scholar
• Compton, W. M., & Volkow, N. D. (2006). Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence, 81, 103–107. doi:10.1016/j.drugalcdep.2005.05.009
   PubMed Web of Science ®Google Scholar
• Hall, W. D., & Lynskey, M. (2005). Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug and Alcohol Review, 24, 39–48. doi:10.1080/09595230500126698
   PubMed Web of Science ®Google Scholar
• Hansen, H., Siegel, C., Wanderling, J., & DiRocco, D. (2016). Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City. Drug and Alcohol Dependence, 164, 14–21. doi:10.1016/j.drugalcdep.2016.03.028
   PubMed Web of Science ®Google Scholar
• Hill, K. P. (2015). Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA, 313, 2474–2483. doi:10.1001/jama.2015.6199
   PubMed Web of Science ®Google Scholar
• Jones, C. W., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015). National and state treatment need and capacity for opioid agonist medication-assisted treatment. American Journal of Public Health, 105, e55. doi:10.2105/AJPH.2015.302664
   PubMed Web of Science ®Google Scholar
• Jones, C. W., Christman, Z., Smith, C. M., Safferman, M. R., Salzman, M., Baston, K., & Haroz, R. (2018). Comparison between buprenorphine provider availability and opioid deaths among US counties. Journal of Substance Abuse Treatment, 93, 19–25. doi:10.1016/j.jsat.2018.07.008
   PubMed Web of Science ®Google Scholar
• Kim, J. H., Santaella-Tenorio, J., Mauro, C., Wrobel, J., Cerdà, M., Keyes, K. M., … Li, G. (2016). State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers. American Journal of Public Health, 106, 2032–2037. doi:10.2105/AJPH.2016.303426
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K., Havens, J. R., Lofwall, M. R., Studts, J. L., & Walsh, S. L. (2017). Buprenorphine physician supply: Relationship with state-level prescription opioid mortality. Drug and Alcohol Dependence, 173, S55–S64. doi:10.1016/j.drugalcdep.2016.08.642
   PubMed Web of Science ®Google Scholar
• Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36, 559–574. doi:10.1146/annurev-publhealth-031914-122957
   PubMed Web of Science ®Google Scholar
• Liang, D., Bao, Y., Wallace, M., Grant, I., & Shi, Y. (2018). Medical cannabis legalization and opioid prescriptions: Evidence on US Medicaid enrollees during 1993–2014. Addiction, 113, 2060–2070. doi:10.1111/add.14382
   PubMed Web of Science ®Google Scholar
• Lynch, M. E., & Campbell, F. (2011). Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials. British Journal of Clinical Pharmacology, 72, 735–744. doi:10.1111/j.1365-2125.2011.03970.x
   PubMed Web of Science ®Google Scholar
• Lynch, M. E., & Ware, M. A. (2015). Cannabinoids for the treatment of chronic non-cancer pain: An updated systematic review of randomized controlled trials. Journal of Neuroimmune Pharmacology, 10, 293–301. doi:10.1007/s11481-015-9600-6
   PubMed Web of Science ®Google Scholar
• Mair, C., Freisthler, B., Ponicki, W. R., & Gaidus, A. (2015). The impacts of marijuana dispensary density and neighborhood ecology on marijuana abuse and dependence. Drug and Alcohol Dependence, 154, 111–116. doi:10.1016/j.drugalcdep.2015.06.019
   PubMed Web of Science ®Google Scholar
• Martín-Sánchez, E., Furukawa, T. A., Taylor, J., & Martin, J. L. R. (2009). Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Medicine, 10, 1353–1368. doi:10.1111/j.1526-4637.2009.00703.x
   PubMed Web of Science ®Google Scholar
• Morral, A. R., McCaffrey, D. F., & Paddock, S. M. (2002). Reassessing the marijuana gateway effect. Addiction, 97, 1493–1504. doi:10.1046/j.1360-0443.2002.00280.x
   PubMed Web of Science ®Google Scholar
• Morrison, C., Gruenewald, P. J., Freisthler, B., Ponicki, W. R., & Remer, L. G. (2014). The economic geography of medical cannabis dispensaries in California. International Journal of Drug Policy, 25, 508–515. doi:10.1016/j.drugpo.2013.12.009
   PubMed Web of Science ®Google Scholar
• Murphy, S. M., Fishman, P. A., McPherson, S., Dyck, D. G., & Roll, J. R. (2014). Determinants of buprenorphine treatment for opioid dependence. Journal of Substance Abuse Treatment, 46, 315–319. doi:10.1016/j.jsat.2013.09.003
   PubMed Web of Science ®Google Scholar
• Olfson, M., Wall, M. M., Liu, S.-M., & Blanco, C. (2017). Cannabis use and risk of prescription opioid use disorder in the United States. American Journal of Psychiatry, 175(1), 47–53. doi:10.1176/appi.ajp.2017.17040413
   Web of Science ®Google Scholar
• Powell, D., Pacula, R. L., & Jacobson, M. (2018). Do medical marijuana laws reduce addictions and deaths related to pain killers? Journal of Health Economics, 58, 29–42.
   PubMed Web of Science ®Google Scholar
• Reisfield, G. M., Wasan, A. D., & Jamison, R. N. (2009). The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: A review of the extant literature. Pain Medicine, 10, 1434–1441. doi:10.1111/j.1526-4637.2009.00726.x
   PubMed Web of Science ®Google Scholar
• Rosenblatt, R. A., Andrilla, C. H. A., Catlin, M., & Larson, E. H. (2015). Geographic and specialty distribution of US physicians trained to treat opioid use disorder. The Annals of Family Medicine, 13(1), 23–26. doi:10.1370/afm.1735
   PubMed Web of Science ®Google Scholar
• SAMHSA. (2004). Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction (Treatment Improvement Protocol #40). Retrieved from https://www.naabt.org/documents/TIP40.pdf
   Google Scholar
• SAMHSA. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-FFR1-2016.htm
   Google Scholar
• Shi, Y. (2016). The availability of medical marijuana dispensary and adolescent marijuana use. Preventive Medicine, 91, 1–7. doi:10.1016/j.ypmed.2016.07.015
   PubMed Web of Science ®Google Scholar
• Shi, Y. (2017). Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. Drug and Alcohol Dependence, 173, 144–150. doi:10.1016/j.drugalcdep.2017.01.006
   PubMed Web of Science ®Google Scholar
• Shi, Y., Liang, D., Bao, Y., An, R., Wallace, M. S., & Grant, I. (2018). Recreational marijuana legalization and prescription opioids received by Medicaid enrollees. Drug and Alcohol Dependence, 194, 13–19.
   PubMed Web of Science ®Google Scholar
• Shi, Y., Meseck, K., & Jankowska, M. M. (2016). Availability of medical and recreational marijuana stores and neighborhood characteristics in Colorado. Journal of Addiction, 2016, 1. doi:10.1155/2016/7193740
   Google Scholar
• Silva, K., Schrager, S. M., Kecojevic, A., & Lankenau, S. E. (2013). Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs. Drug and Alcohol Dependence, 128(1-2), 104–110. doi:10.1016/j.drugalcdep.2012.08.014
   PubMed Web of Science ®Google Scholar
• Stockwell, T., & Gruenewald, P. (2004). Controls on the physical availability of alcohol. In N. Heather & T. Stockwell (Eds.), The essential handbook of treatment and prevention of alcohol problems (pp. 213–234). New York: John Wiley.
   Google Scholar
• Volkow, N. D. (2014). America's addiction to opioids: Heroin and prescription drug abuse. Retrieved from https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2014/americas-addiction-to-opioids-heroin-prescription-drug-abuse
   Google Scholar
• Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication-assisted therapies—Tackling the opioid-overdose epidemic. New England Journal of Medicine, 370, 2063–2066. doi:10.1056/NEJMp1402780
   PubMed Web of Science ®Google Scholar
• SB 5052 - 2015-16. (2015). Establishing the Cannabis Patient Protection Act. Olympia, Washington: Washington State Legislature.
   Google Scholar
• Warner-Smith, M., Darke, S., & Day, C. (2002). Morbidity associated with non-fatal heroin overdose. Addiction, 97, 963–967. doi:10.1046/j.1360-0443.2002.00132.x
   PubMed Web of Science ®Google Scholar
• Warner, M., Hedegaard, H., & Chen, L. H. (2014). Trends in drug-poisoning deaths involving opioid analgesics and heroin: United States, 1999–2012. Retrieved from https://www.cdc.gov/nchs/data/hestat/drug_poisoning/drug_poisoning.htm
   Google Scholar
• Weiss, A., Elixhauser, A., Barrett, M., Steiner, C., Bailey, M., & O’Malley, L. (2016). Opioid-related inpatient stays and emergency department visits by state, 2009–2014. Retrieved from https://www.hcup-us.ahrq.gov/reports/statbriefs/sb219-Opioid-Hospital-Stays-ED-Visits-by-State.pdf
   Google Scholar
• Wen, H., & Hockenberry, J. M. (2018). Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Internal Medicine, 178, 673–679. doi:10.1001/jamainternmed.2018.1007
   PubMed Web of Science ®Google Scholar
• Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., … Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313, 2456–2473. doi:10.1001/jama.2015.6358
   PubMed Web of Science ®Google Scholar